诱导血管正常化 - - 可以强迫瘤屈服于更好的微环境吗?
Xu Xin Sun1,2,3,4, Zeynab Nosrati1,2,4, Janell Ko1
1Experimental Therapeutics, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Pharmaceutics
|August 26, 2023
概括
增强癌症免疫疗法包括将治疗与药物输送系统相结合. 这种方法旨在使瘤血管正常化并改善免疫细胞功能,以获得更好的患者生存结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫疗法已经彻底改变了癌症治疗,但需要进一步改善患者的生存率.
- 提高免疫疗法的有效性需要新的组合策略.
- 瘤血管生成和瘤微环境显著影响免疫疗法反应.
研究的目的:
- 探索用于增强癌症免疫治疗的创新组合策略.
- 研究药物输送系统在改善免疫治疗结果中的作用.
- 确定未来的治疗方法,使癌症患者的整体生存率增加一倍.
主要方法:
- 审查当前的免疫治疗研究和癌症血管生成.
- 分析影响瘤微环境和免疫细胞的主要血管生成点.
- 对促进瘤血管正常化的药物输送系统的评估.
主要成果:
- 将瘤血管正常化和改变免疫微环境的组合疗法显示出有希望.
- 药物输送系统为增强血管正常化提供了潜力.
- 向血管生成可以调节瘤微环境以支持免疫治疗.
结论:
- 将免疫疗法与血管正常化策略相结合,对未来的癌症治疗有很大的潜力.
- 药物输送系统是实现免疫治疗治疗效果的关键.
- 优化瘤微环境对于最大限度地提高免疫治疗效益至关重要.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanism of Angiogenesis
5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555


